Vitrafy Life Sciences Enters Partnership with US Blood Bank to Expand Cryopreservation Ecosystem for Red Blood Cells, Shares Jump 11%

MT Newswires Live

07/23

Vitrafy Life Sciences (ASX:VFY) entered a partnership with Hoxworth Blood Center in the US to expand the firm's cryopreservation ecosystem in response to the end-of-life of legacy red blood cell cryopreservation technology, according to a Thursday Australian bourse filing.

The firm said it was working to address red blood cell cryopreservation workflows resulting from the discontinuation of critical legacy technology starting in 2027. The agreement is not expected to generate revenue.

Under the partnership, Vitrafy and Hoxworth will both contribute resources and support in addressing this threat. Vitrafy will initially place one cryopreservation freezing and software package at Hoxworth during the first half of fiscal year 2027.

Its shares jumped 11% in recent trading on Thursday.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2653792217"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2653792217\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2653792217?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-23 08:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2653792217","market":"sh","top_or_hot":-1,"title":"Vitrafy Life Sciences Enters Partnership with US Blood Bank to Expand Cryopreservation Ecosystem for Red Blood Cells, Shares Jump 11%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/VFY.AU\">Vitrafy Life</a> Sciences (ASX:VFY) entered a partnership with Hoxworth Blood Center in the US to expand the firm's cryopreservation ecosystem in response to the end-of-life of legacy red blood cell cryopreservation technology, according to a Thursday Australian bourse filing.</p><p>The firm said it was working to address red blood cell cryopreservation workflows resulting from the discontinuation of critical legacy technology starting in 2027. The agreement is not expected to generate revenue.</p><p>Under the partnership, Vitrafy and Hoxworth will both contribute resources and support in addressing this threat. Vitrafy will initially place one cryopreservation freezing and software package at Hoxworth during the first half of fiscal year 2027.</p><p>Its shares jumped 11% in recent trading on Thursday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vitrafy Life Sciences Enters Partnership with US Blood Bank to Expand Cryopreservation Ecosystem for Red Blood Cells, Shares Jump 11%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVitrafy Life Sciences Enters Partnership with US Blood Bank to Expand Cryopreservation Ecosystem for Red Blood Cells, Shares Jump 11%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-23 08:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/VFY.AU\">Vitrafy Life</a> Sciences (ASX:VFY) entered a partnership with Hoxworth Blood Center in the US to expand the firm's cryopreservation ecosystem in response to the end-of-life of legacy red blood cell cryopreservation technology, according to a Thursday Australian bourse filing.</p><p>The firm said it was working to address red blood cell cryopreservation workflows resulting from the discontinuation of critical legacy technology starting in 2027. The agreement is not expected to generate revenue.</p><p>Under the partnership, Vitrafy and Hoxworth will both contribute resources and support in addressing this threat. Vitrafy will initially place one cryopreservation freezing and software package at Hoxworth during the first half of fiscal year 2027.</p><p>Its shares jumped 11% in recent trading on Thursday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7048","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2653792217","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2653792217","pubTimestamp":1784768019,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Vitrafy Life Sciences  entered a partnership with Hoxworth Blood Center in the US to expand the firm's cryopreservation ecosystem in response to the end-of-life of legacy red blood cell cryopreservation technology, according to a Thursday Australian bourse filing.The firm said it was working to address red blood cell cryopreservation workflows resulting from the discontinuation of critical legacy technology starting in 2027. The agreement is not expected to generate revenue.Under the partnership, Vitrafy and Hoxworth will both contribute resources and support in addressing this threat. Vitrafy will initially place one cryopreservation freezing and software package at Hoxworth during the first half of fiscal year 2027.Its shares jumped 11% in recent trading on Thursday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7048":"生命科学工具和服务","VFY.AU":"Vitrafy Life Sciences Ltd"},"translate_title":"Vitrafy Life Sciences 与美国血库合作扩大红细胞冷冻保存生态系统，股价上涨 11%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VFY.AU":1},"content_text":"Vitrafy Life Sciences (ASX:VFY) entered a partnership with Hoxworth Blood Center in the US to expand the firm's cryopreservation ecosystem in response to the end-of-life of legacy red blood cell cryopreservation technology, according to a Thursday Australian bourse filing.The firm said it was working to address red blood cell cryopreservation workflows resulting from the discontinuation of critical legacy technology starting in 2027. The agreement is not expected to generate revenue.Under the partnership, Vitrafy and Hoxworth will both contribute resources and support in addressing this threat. Vitrafy will initially place one cryopreservation freezing and software package at Hoxworth during the first half of fiscal year 2027.Its shares jumped 11% in recent trading on Thursday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}